Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

11.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma.

Science translational medicine·2025
Same author

Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma.

Neuro-oncology·2025
Same author

Manganese Porphyrin Reduces Oxidative Stress in Vulnerable Parkin-Null <i>Drosophila</i> Dopaminergic Neurons.

Antioxidants (Basel, Switzerland)·2025
Same author

Suppression of Paclitaxel-Induced Neuropathy and Ovarian Tumor Growth by Mn Porphyrin, MnTnBuOE-2-PyP<sup>5+</sup> (BMX-001).

Oxidative medicine and cellular longevity·2025
Same author

park+/+ and park-/- Drosophila have sexually dimorphic brain redox chemistry.

Disease models & mechanisms·2025
Same author

Protoporphyrin IX plasma and blood pharmacokinetics and brain tumor distribution determined by a validated LC-MS/MS method.

Scientific reports·2025

Related Experiment Video

Updated: Mar 20, 2026

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
05:13

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

Published on: January 24, 2025

886

Important cellular targets for antimicrobial photodynamic therapy.

Mariam M Awad1, Artak Tovmasyan2, James D Craik1

  • 1Department of Biochemistry, Faculty of Medicine, Kuwait University, P. O. Box 24923, Safat, 13110, Kuwait.

Applied Microbiology and Biotechnology
|May 26, 2016
PubMed
Summary

Photodynamic inactivation (PDI) offers a promising approach to combat antibiotic resistance. This method effectively kills bacteria by damaging multiple cellular targets, not just DNA, reducing the likelihood of resistance development.

Keywords:
AntimicrobialGram-negativePhotodynamic inactivationSinglet oxygen

More Related Videos

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
04:48

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans

Published on: March 24, 2022

3.8K
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

3.9K

Related Experiment Videos

Last Updated: Mar 20, 2026

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
05:13

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

Published on: January 24, 2025

886
Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
04:48

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans

Published on: March 24, 2022

3.8K
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

3.9K

Area of Science:

  • Microbiology
  • Biochemistry
  • Photochemistry

Background:

  • Antibiotic resistance poses a significant global health threat, driving the need for novel antimicrobial strategies.
  • Photodynamic inactivation (PDI) utilizes photosensitizers and light to generate reactive species for microbial killing.
  • The precise molecular targets and mechanisms underlying PDI's effectiveness, particularly against antibiotic-resistant strains, require further elucidation.

Purpose of the Study:

  • To investigate the molecular targets of photodynamic inactivation (PDI) in bacteria.
  • To determine if DNA modification is essential for efficient bacterial photoinactivation.
  • To explore alternative cellular targets contributing to PDI efficacy.

Main Methods:

  • Utilized Zinc porphyrin-based photosensitizers (PSs).
  • Employed Escherichia coli as a model Gram-negative bacterium.
  • Analyzed cellular damage and modifications following PDI treatment.

Main Results:

  • Demonstrated efficient photoinactivation of E. coli without significant DNA modification.
  • Identified early PDI-induced damage in cytosolic enzymes, membrane-bound protein complexes, and the plasma membrane.
  • Observed disruption of membrane barrier function and compromised energy production.

Conclusions:

  • Effective antimicrobial PDI can be achieved through damage to multiple cellular components, not solely DNA.
  • Disruption of membrane integrity and cellular metabolism are key contributors to PDI-induced cell death.
  • PDI's multi-target mechanism may lower the probability of resistance development in microorganisms.